Biotech

All Articles

Relay drops 10% of workers after earlier discharges in July

.Accuracy medication biotech Relay Rehabs is losing about 10% of its own labor force in initiatives ...

Pentixapharm scores $22M IPO to advance radiopharma tests

.Pentixapharm has produced just about twenty million europeans ($ 22 million) coming from an IPO, al...

Lundbeck taps Charles Waterway for AI-enabled neuro medication discovery

.Lundbeck has utilized Charles Stream Laboratories' expert system abilities to help the invention of...

Big pharma, biotech 'will not essentially be cooperative' in artificial intelligence: S&ampP

.Major Pharma is actually putting in heavily in artificial intelligence to lower progression timetab...

I &amp I biotech Triveni raises $115M for preclinical antibodies

.Triveni Bio has actually trapped $115 thousand in collection B funds to evolve preclinical antibody...

IGM rotates from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences finished in 2014 giving up workers and streamlining its cancer pipe. Now, the provi...

Shattuck axes CD47 plan over weak effectiveness records, lays off 40% of staff and also sheds Ono work

.Shattuck Labs has actually hammered an additional nail in to the casket of CD47. After viewing a "r...

BioMarin goes Outdoor camping, striking RNA cope with biotech

.BioMarin is adding firewood to the R&ampD fire, attacking a fit with CAMP4 Therapeutics for legal r...

Cash- strapped Gritstone starts hunt for strategic alternatives as cancer injection data underwhelm

.Gritstone bio has generated lenders to look into "possible value-maximizing strategies" after its o...

Kailera launches with $400M series A, 4 Chinese weight problems medicines

.Kailera Therapies has actually launched into the increasingly jampacked obesity area along with a p...